Alrex Suspension/ Drops
Product Images NDC 24208-353

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alrex (NDC 24208-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Alrex

Alrex is a sterile ophthalmic suspension for topical ophthalmic use only. It contains Loteprednol Etabonate 2 mg (0.2%) as the active ingredient and benzalkonium chloride 0.01% as the preservative. The suspension is isotonic with a tonicity of 250 to 310 mOsmol/kg. It is essentially composed of edetate disodium, glycerin, povidone, purified water, and tyloxapol. Alrex should be kept out of reach of children and should not be used if the neckband is missing or the protective seal is not intact. Prior to use, it should be shaken vigorously. Bausch & Lomb Americas Inc. distributes Alrex, while Bausch & Lomb Incorporated manufactures it.*

FDA Label Image

Chemical Structure

This is a molecular weight value of a chemical compound.*

FDA Label Image

Image 01

This text is a warning label instructing the user not to use a neckband if it does not have an intact yellow protective seal.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.